Completed NA INTERVENTIONAL 2-arm NCT03010254

A Clinical Study of the ACRYSOF® IQ EDF Intraocular Lens (IOL)

A Prospective, Randomized, Controlled, Multi-Center Clinical Study of the ACRYSOF® IQ Extended Depth of Focus (EDF) IOL

Sponsor: Alcon Research

Conditions Cataract

Interventions ACRYSOF® IQ Extended Depth of Focus IOL ACRYSOF® IQ Monofocal IOL Cataract surgery

Updated 11 times since 2017 Last updated: Mar 25, 2020 Started: Mar 21, 2017 Primary completion: Aug 17, 2018 Completion: Oct 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cataract and is currently completed. Alcon Research leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2020 — Jan 2021 [monthly]

Completed NA

Status: Withheld → Completed · Phase: None → NA

▶ Show 6 earlier versions

Sep 2019 — May 2020 [monthly]

Withheld
Dec 2018 — Sep 2019 [monthly]

Withheld
Oct 2018 — Dec 2018 [monthly]

Withheld
Jun 2018 — Oct 2018 [monthly]

Withheld
Apr 2018 — Jun 2018 [monthly]

Withheld

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Withheld NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alcon Research

Data source: Alcon Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Barcelona, Spain , Boisbriand, Canada , Dartford, United Kingdom , Essex, United Kingdom , Footscray, Australia , Hawthorn East, Australia , Jerez de la Frontera, Spain , London, United Kingdom , Madrid, Spain , Manchester, United Kingdom and 8 more locations